US Physical Therapy (USPH) Misses Q3 EPS by 2c, Cuts FY11 EPS Guidance
Tweet
Share
E-mailGet Alerts USPH Hot Sheet
Price: $79.35 +0.90%
Revenue Growth %: +8.5%
Financial Fact:
Net income attributable to common shareholders: 5.71M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +8.5%
Financial Fact:
Net income attributable to common shareholders: 5.71M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
US Physical Therapy, Inc. (NASDAQ: USPH) reported Q3 EPS of $0.34, $0.02 worse than the analyst estimate of $0.36. Revenue for the quarter came in at $59.68 million versus the consensus estimate of $59.33 million.
US Physical Therapy, Inc. sees FY2011 EPS of $1.31-$1.35, versus prior guidance of $1.38-$1.43 and the consensus of $1.41.
US Physical Therapy, Inc. sees FY2011 EPS of $1.31-$1.35, versus prior guidance of $1.38-$1.43 and the consensus of $1.41.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- Torrid Holdings Inc. (CURV) Tops Q2 EPS by 8c; Offers Guidance
- Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
